sprite-preloader
Anzeige
Mehr »
Freitag, 22.02.2019 Börsentäglich über 12.000 News von 595 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
09:42Morphic Therapeutic enters into integrin research and development collaboration with Janssen
09:42Merck to buy late-stage immunotherapy firm Immune Design for $300m
08:42Amgen and partners begin second phase 3 trial of omecamtiv mecarbil in patients with heart failure
DoSosei Heptares doses first patient in trial targeting endocrine disorders
DoIndivior introduces generic version of Suboxone opioid drug in US
DoPeloton Therapeutics secures $150m in Series E financing
MiInnovation Pharmaceuticals receives new patent for compounds for use in treatment of oral mucositis
MiRoche secures FDA priority review for entrectinib and polatuzumab vedotin
MiMerck gets FDA nod for Keytruda as adjuvant treatment for melanoma
MiPfizer secures approval from European Commission for Avastin biosimilar
DiInnovent, Chipscreen Biosciences to evaluate combination therapy in colorectal cancer patients
DiKnight signs Latin American strategic funding deal with Moksha8
DiAdditional data analysis offers greater insight into phase 2 findings of Bionomics' PTSD drug
MoDecipher announces research collaboration with Dendreon to identify genomic drivers of patient response to Sipuleucel-T
MoBavencio plus Inlyta improves median PFS in renal carcinoma study
MoArtificial intelligence can predict survival of ovarian cancer patients
15.02.FDA declines to approve Motif Bio's iclaprim for ABSSSI treatment
15.02.SK, Arvelle sign $530m deal for antiepileptic drug cenobamate
15.02.Vor Biopharma receives $42m funds to advance development of cell therapy product candidate for acute myeloid leukemia
15.02.Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
14.02.World's largest pharmaceutical firm selects ValGenesis to standardize corporate validation process enterprise-level
14.02.FDA approves Novartis' Egaten to treat fascioliasis
14.02.Mayne Pharma launches Lexette (halobetasol propionate) foam 0.05% in the US
13.02.FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer's disease
13.02.US court rejects Indivior's appeal on Suboxone generic version